Document:

Exhibit 10.1

 

SHARE PURCHASE AGREEMENT

 

This Share Purchase
Agreement (this “Agreement”) is dated as of January 13, 2016 among iBio, Inc., a Delaware corporation (the “Company”),
and Eastern Capital Limited, a Cayman Islands corporation (including its successors and assigns, the “Purchaser”).

 

WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the
“Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchaser,
and the Purchaser desires to purchase from the Company, shares of common stock of the Company, as more fully described in this
Agreement.

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1  Definitions.
In addition to the terms defined elsewhere in this Agreement the following terms have the meanings set forth in this Section 1.1:

 

“Additional
Listing Application” means an application for the listing of the Shares with the NYSE MKT in the form required by the
NYSE MKT.

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. With respect to the Purchaser,
any investment fund or managed account that is managed on a discretionary basis by the same investment manager as the Purchaser
will be deemed to be an Affiliate of the Purchaser. For the purposes of this Agreement, the Company and its Subsidiaries will not
be deemed an Affiliate of Purchaser or its subsidiaries and the Purchaser and its subsidiaries will not be deemed an Affiliate
of the Company or its Subsidiaries.

 

“Board of
Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Closing”
shall have the meaning assigned to such term in Section 2.1.

 

“Closing Date”
shall have the meaning assigned to such term in Section 2.1.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, par value $0.001 per share.

 

     

     

    

 

“Company Counsel”
means Andrew Abramowitz, PLLC, with offices located at 565 Fifth Avenue, 9th Floor, New York, New York 10017.

 

“Disclosure
Schedules” shall have the meaning assigned to such term in Section 3.1.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Financial
Statements” shall have the meaning assigned to such term in Section 3.1(f).

 

“GAAP”
shall have the meaning assigned to such term in Section 3.1(f).

 

“Indemnified
Liability” shall have the meaning assigned to such term in Section 4.5.

 

“Indemnified
Persons” shall have the meaning assigned to such term in Section 4.5.

 

“Intellectual
Property Rights” shall have the meaning assigned to such term in Section 3.1(l).

 

“Liens”
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other similar restriction.

 

“Losses”
shall have the meaning assigned to such term in Section 4.5.

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(a).

 

“Outside Date”
shall have the meaning assigned to such term in Section 5.1(a).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Purchase
Amount” shall have the meaning assigned to such term in Section 2.1.

 

“Purchaser
Party” shall have the meaning assigned to such term in Section 4.6.

 

“Purchaser
Statements” shall have the meaning assigned to such term in Section 3.2(h).

 

“Required
Approvals” shall have the meaning assigned to such term in Section 3.1(d).

 

“SEC Documents”
shall have the meaning assigned to such term in Section 3.1(f).

 

“Shares”
shall have the meaning assigned to such term in Section 2.1.

 

    	 	2	 

     

    

 

“Subsidiary”
means any direct or indirect subsidiary of the Company and shall, where applicable, include any direct or indirect subsidiary of
the Company formed or acquired after the date hereof.

 

“Trading Day”
means a day on which the New York Stock Exchange is open for trading.

 

“Trading Market”
means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: NYSE
MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange or the
OTC Bulletin Board.

 

“Transaction
Documents” means this Agreement and all exhibits and schedules hereto.

 

“Transfer
Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company with a mailing
address of 17 Battery Place, New York, New York 10004, and any successor transfer agent of the Company.

 

“Warrants”
shall have the meaning assigned to such term in Section 2.1.

 

“Warrant Shares”
shall have the meaning assigned to such term in Section 2.1.

 

ARTICLE II

PURCHASE AND SALE

 

2.1  Purchase
and Sale; Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to
sell, and the Purchaser agrees to purchase 3,500,000 shares of Common Stock (the “Shares”), for a per Share
purchase price of $0.622, resulting in an aggregate purchase price of $2,177,000 (the “Purchase Amount”). Simultaneously
with the closing of the sale and purchase of Shares hereunder, the Purchaser shall exercise its Warrants, dated April 26, 2013
(the “Warrants”), to purchase 1,784,000 shares of Common Stock (“Warrant Shares”), in accordance
with the procedures set forth in the Warrants. Subject to the satisfaction of the conditions set forth in Section 2.3, the closing
of the transactions contemplated hereunder (the “Closing”) shall occur at the offices of Company Counsel on
the third Trading Day following the date that the Additional Listing Application for the Shares is approved by the NYSE MKT or
such other place or such other date as the parties may mutually agree (the “Closing Date”).

 

2.2  Closing
Deliveries.

 

(a)  On the
Closing Date, the Company shall deliver or cause to be delivered to the Purchaser irrevocable instructions to the Transfer Agent
instructing the Transfer Agent to deliver a certificate evidencing the Shares registered in the name of the Purchaser.  

 

(b)  On the
Closing Date, the Purchaser shall deliver or cause to be delivered to the Company (i) the Purchase Amount by wire transfer of immediately
available funds to the account notified in writing by the Company, and (ii) a duly executed Notice of Exercise in the form attached
to the Warrants, exercising the Purchaser’s right to purchase all of the Warrant Shares, together with the exercise price
for such Warrant Shares as provided in the Warrants.

 

    	 	3	 

     

    

 

2.3  Closing
Conditions.

 

(a)  The
obligations of the Company hereunder to effect the Closing are subject to the following conditions being met:  

 

(i)  the
representations and warranties of the Purchaser contained in this Agreement (A) that are not qualified as to “materiality”
shall be true and correct in all material respects as of the Closing Date, and (B) that are qualified as to “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are made as of another
date, in which case such representations and warranties shall be true and correct in all material respects or true and correct,
as the case may be, as of such specified date;

 

(ii)  the
NYSE MKT shall have approved the Additional Listing Application for the Shares; and

 

(iii)  all
obligations, covenants and agreements of the Purchaser required to be performed at or prior to the Closing Date shall have been
performed.

 

(b)  The
obligations of the Purchaser hereunder to effect the Closing are subject to the following conditions being met:

 

(i)  the
representations and warranties of the Company contained in this Agreement (A) that are not qualified as to “materiality”
shall be true and correct in all material respects as of the Closing Date, and (B) that are qualified as to “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are made as of another
date, in which case such representations and warranties shall be true and correct in all material respects or true and correct,
as the case may be, as of such specified date;

 

(ii)  the
NYSE MKT shall have approved the Additional Listing Application for the Shares;

 

(iii)  all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

 

(iv)  there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v)  from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s
principal Trading Market (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall
be terminated prior to the Closing).

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES

 

3.1  Representations
and Warranties of the Company. Except as set forth under the corresponding section of the disclosure schedules delivered to
the Purchaser concurrently herewith (the “Disclosure Schedules”), attached hereto as Exhibit A, which
Disclosure Schedules shall be deemed a part hereof, the Company hereby makes the representations and warranties set forth below
to the Purchaser as of the date hereof and as of the Closing Date (or if a date is specified in a representation or warranty, as
of such specified date):

 

    	 	4	 

     

    

 

(a)   Organization
and Qualification. The Company is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the State of Delaware, with the requisite power and authority to own and use its properties and assets and to
carry on its business as currently conducted. The Company is not in violation or default of any of the provisions of its certificate
of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct business and is
in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be,
could not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, properties or condition
(financial or otherwise) of the Company and its Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or
(iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(b)  Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by each of the Transaction Documents, to issue the Shares in accordance with the terms hereof and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of the Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby, including the issuance of the Shares, have been duly authorized by all
necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s
stockholders in connection therewith other than in connection with the Required Approvals. Each Transaction Document has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except
as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of
general application affecting enforcement of creditors’ rights generally.

 

(c)  No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the other transactions contemplated hereby and thereby (including, without limitation, the issuance of the Shares) do
not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company
or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result
in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations and the
rules and regulations of any Trading Market on which the Common Stock is traded or quoted), or by which any property or asset of
the Company or a Subsidiary is bound or affected, except in the cases of conflicts described in clauses (ii) or (iii) that would
not have a Material Adverse Effect.

 

    	 	5	 

     

    

 

(d)  Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, including but not
limited to the issuance and sale of Shares, other than (i) filings required pursuant to the Exchange Act, (ii) the filing of Form
D with the Commission and such filings as are required to be made under applicable state securities laws, and (iii) the filing
of the Additional Listing Application (collectively, the “Required Approvals”) and filings which if not made
would not result in a Material Adverse Effect.

 

(e)  Issuance
of the Shares. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all taxes and charges with respect thereof and
free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.
The issuance of the Shares as contemplated hereunder will not violate any preemptive or similar rights of the holders of any shares
of Common Stock or other securities of the Company.

 

(f)  SEC
Reports. The Company has filed all reports required to be filed by it under the Exchange Act, for the previous
two years (or such shorter period as the Company was required by law to file such material) (all of the foregoing and all exhibits
included therein and financial statements and schedules thereto and documents incorporated by reference therein, being hereinafter
referred to as the “SEC Documents”). As of their respective dates, the SEC Documents complied in all material
respects as to form with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Documents, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The Company has advised the Purchaser that a correct and complete copy of each of the
SEC Documents (together with all exhibits and schedules thereto and as amended to date) is available at http://www.sec.gov,
a website maintained by the Commission where the Purchaser may view the SEC Documents. The financial statements of the Company
included in the SEC Documents (the “Financial Statements”) comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in all material respects in accordance with generally accepted accounting principles applied on a
consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial
statements or the notes thereto, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended.

 

    	 	6	 

     

    

 

(g)  Brokers.
The Company has not employed any unaffiliated broker or finder, or incurred any liability for any brokerage or finders fees or
any similar fees or commissions in connection with the transactions contemplated by this Agreement.

 

(h)  Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as disclosed in the SEC Documents, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market.

 

(i)  Material
Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest quarterly financial statements included
within the SEC Reports, except as specifically disclosed in the SEC Reports, (A) there has been no event, occurrence of development
that has had or could reasonably be expected to result in a Material Adverse Effect, (B) the Company has not incurred any liabilities
(contingent or otherwise) other than (x) trade payables and accrued expenses incurred in the ordinary course of business consistent
with past practice and (y) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP
or required to be disclosed in filings made with the Commission, (D) the Company has not altered its method of accounting, (E)
the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed,
or made any agreements to purchase or redeem any shares of its capital stock and (F) the Company has not issued any equity securities
to any officer, director or Affiliate, except pursuant to existing Company stock option plans.

 

(j)  Private
Placement. Assuming the accuracy of the representations and warranties of the Purchaser set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Shares by the Company as contemplated hereby.

 

(k)  No
Integrated Offering. With the exception of any other anticipated purchase of Common Stock from the Company by the Purchaser,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
of the Shares to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the
registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading
Market on which any of the securities of the Company are listed or designated.

 

(l)  Intellectual
Property. Except as set forth in the SEC Reports, to the Company’s knowledge, the Company and the Subsidiaries have,
or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade
secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described in the SEC Reports
as necessary or required for use in connection with their respective businesses and which the failure to so have would have a Material
Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any
Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or
been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon
the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and, to the knowledge of the Company, there is no existing
infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

    	 	7	 

     

    

 

3.2  Representations
and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as of the date hereof and as of the Closing
Date (or if a date is specified in a representation or warranty, as of such specified date) as follows:

 

(a)  Organization;
Authority. The Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with full right, corporate or partnership power and authority to enter into and to consummate the transactions
contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and
delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary corporate or similar action on the part of the Purchaser. Each Transaction Document
to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms
hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its
terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(b)  Own
Account. The Purchaser understands that the Shares are “restricted securities” and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Shares as principal for its own account and not
with a view to or for distributing or reselling such Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Shares in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding
the distribution of such Shares in violation of the Securities Act or any applicable state securities law.

 

    	 	8	 

     

    

 

(c)  Purchaser
Status. At the time the Purchaser was offered the Shares, it was, and at the date hereof it is an “accredited investor”
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act. The Purchaser is not required to be registered
as a broker-dealer under Section 15 of the Exchange Act. The information set forth in the Accredited Investor Questionnaire completed
by the Purchaser and delivered to the Company is complete and accurate.

 

(d)  Experience
of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Shares, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of
an investment in the Shares and, at the present time, is able to afford a complete loss of such investment. The Purchaser (i) has
adequate means of providing for its current needs in the same manner as it would have been able to provide prior to making the
investment in the Shares, (ii) has no need for liquidity in this investment, (iii) is aware of and able to bear the risks
of this investment for an indefinite period of time and (iv) is presently able to afford a complete loss of such investment.

 

(e)  General
Solicitation. The Purchaser is not purchasing the Shares as a result of any advertisement, article, notice or other communication
regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement.

 

(f)  Information.
The Purchaser represents that it has access to and has reviewed copies of the Company’s SEC Documents and each of the exhibits
attached hereto. The Purchaser and its attorneys, investment advisors, business advisors, tax advisors and accountants have had
sufficient access to all documents and records pertaining to the Company and this proposed investment, including but not limited
to the SEC Documents and the exhibits attached hereto. Additionally, the Purchaser and all of its advisors have had the opportunity
to ask questions and receive answers concerning the terms and conditions of the offering and other matters pertaining to this investment,
and all such questions have been answered to the satisfaction of the Purchaser. The Purchaser and all of its advisors have had
an opportunity to obtain any additional information which the Company possesses, or can acquire without unreasonable effort or
expense, necessary to verify the accuracy of the information furnished in the SEC Documents and any exhibits attached hereto.

 

(g)  Risk/Lack
of Market. The Purchaser recognizes that an investment in the Shares involves significant risks, including, without limitation,
those set forth in the SEC Documents. The Purchaser acknowledges that the Company’s continued operation is highly dependent
upon its ability to raise substantial additional capital and/or increase revenues. No assurance can be given that the Company will
be successful in raising any such capital and/or increasing revenues. The failure to raise such capital and/or increase revenues
will have a material adverse effect on the Company’s operations and financial condition. The Purchaser realizes that it may
not be able to sell or dispose of any of the Shares and that no market of any kind (public or private) may be available for
any of the Shares at the time the Purchaser elects to sell its Shares. In addition, the Purchaser understands that its right to
transfer the Shares will be subject to restrictions contained in applicable federal and state securities laws.

 

    	 	9	 

     

    

 

(h)  Accuracy
of Representations of Purchaser. The representations, warranties and agreements made by the Purchaser herein have been made
with the intent that they be relied upon by the Company for purposes of the transactions contemplated by this Agreement. The Purchaser
represents and warrants that none of the representations or warranties made by the Purchaser herein or the Accredited Investor
Questionnaire submitted by the Purchaser to the Company (“Purchaser Statements”) contains any false or misleading
statement or omits to state a material fact.

 

ARTICLE IV

OTHER AGREEMENTS OF THE PARTIES

 

4.1  Transfer
Restrictions.

 

(a)  The
Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Shares
other than pursuant to an effective registration statement or an exemption under the Securities Act, the Company may require the
transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the
Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Shares under the Securities Act. As a condition of any transfer, any such transferee,
other than with respect to a transfer pursuant to a registration statement or an exemption under the Securities Act, shall agree
in writing to be bound by the terms of this Agreement and shall have the rights of the Purchaser under this Agreement.

 

(b)  The
Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares substantially
in the following form:

 

THESE SHARES HAVE NOT
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL
BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

4.2  Additional
Listing Application. Promptly following the date hereof, the Company shall submit the Additional Listing Application to the
NYSE MKT.

 

4.3  Use
of Proceeds. The Company shall use the net proceeds from the sale of the Shares hereunder for general corporate purposes.

 

4.4  Form
D. The Company agrees to timely file a Form D with respect to the Shares as required under Regulation D and to provide a copy
thereof, promptly upon request of the Purchaser.

 

    	 	10	 

     

    

 

4.5  Indemnification
by Purchaser. The Purchaser shall indemnify the Company and its stockholders, directors, officers, employees, agents and any
of the affiliates of the foregoing (the “Indemnified Persons”) and hold harmless the Indemnified Persons from
and against any and all loss, cost, liability, damages, penalties, actions, suits, and expenses (including reasonable attorneys’
fees and other legal expenses) (“Losses”) which may be imposed upon, asserted against, paid or incurred by the
Indemnified Persons (except and only to the extent that the same arises solely from gross negligence or willful misconduct on the
part of an Indemnified Person) at any time or from time to time in connection with the enforcement of the terms hereof or of any
Transaction Document against the Purchaser, or related to the consummation of the transactions contemplated hereby or under any
Transaction Document with respect to the Purchaser, including the prosecution or defense of any suit against the Purchaser relating
to or arising out of this Agreement or any Transaction Document, or any breach by the Purchaser of its representations and warranties
hereunder or under any Transaction Document or the default by the Purchaser under this Agreement or any Transaction Document (collectively
the “Indemnified Liability”); provided, however, that the Purchaser shall not be liable for the
payment to any Indemnified Person of any portion of such Indemnified Liability resulting from the gross negligence or willful misconduct
on the part of an Indemnified Person. If any action shall be brought against any Indemnified Person in respect of which indemnity
may be sought pursuant to this Agreement, such Indemnified Person shall promptly notify the Purchaser in writing, and the Purchaser
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Indemnified Person.
Any Indemnified Person shall have the right to employ separate counsel in any such action and participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Indemnified Person except to the extent that (i) the
employment thereof has been specifically authorized by the Purchaser in writing, (ii) the Purchaser has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such
separate counsel, a material conflict on any material issue between the position of the Purchaser and the position of such Indemnified
Person, in which case the Purchaser shall be responsible for the reasonable fees and expenses of no more than one such separate
counsel. The Purchaser will not be liable to any Indemnified Person under this Agreement (i) for any settlement by a Indemnified
Person effected without the Purchaser’s prior written consent, which shall not be unreasonably withheld or delayed or (ii)
to the extent, but only to the extent, that a loss, claim, damage or liability is attributable to any Indemnified Person’s
breach of any of the representations, warranties, covenants or agreements made by such Indemnified Person in this Agreement or
any Transaction Document.

 

4.6  Indemnification
by Company. The Company shall indemnify the Purchaser and its directors, officers, shareholders, members, partners, employees
and agents (each, a “Purchaser Party”) and hold harmless the Purchaser Parties from and against any and all
Losses which may be imposed upon, asserted against, paid or incurred by the Purchaser Parties (except and only to the extent that
the same arises solely from gross negligence or willful misconduct on the part of a Purchaser Party) at any time or from time to
time in connection with (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in
this Agreement or any Transaction Document or (b) any action instituted against the Purchaser, or any of its Affiliates, by any
stockholder of the Company who is not an Affiliate of the Purchaser, with respect to any of the transactions contemplated by this
Agreement (unless such action is based upon a breach of the Purchaser’s representations, warranties or covenants under this
Agreement or any agreements or understandings the Purchaser may have with any such stockholder or any violations by the Purchaser
of state or federal securities laws or any conduct by the Purchaser which constitutes fraud, gross negligence, willful misconduct
or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant
to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume
the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have
the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such
counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and
to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on
any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall
be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to
any Purchaser Party under this Agreement (i) for any settlement by a Purchaser Party effected without the Company’s prior
written consent, which shall not be unreasonably withheld or delayed or (ii) to the extent, but only to the extent, that a loss,
claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants
or agreements made by such Purchaser Party in this Agreement or any Transaction Document.

 

    	 	11	 

     

    

 

ARTICLE V

MISCELLANEOUS

 

5.1  Termination.
This Agreement may be terminated at any time prior to the Closing:

 

(a)  by either
the Company or the Purchaser, if the Closing shall not have occurred by March 31, 2016 (the “Outside Date”);
provided, however, that the right to terminate this Agreement under this Section 5.1(a) shall not be available to
any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in,
the failure of the Closing to occur on or prior to such date;

 

(b)  by either
the Company or the Purchaser if there shall be in effect any final and nonappealable law, order or other legal restraint or prohibition
by any governmental, regulatory, listing or administrative authority, agency or commission or any court, tribunal or judicial body
preventing or making illegal the consummation of the transactions contemplated hereby;

 

(c)  by the
Company if the Purchaser shall have breached any of its representations, warranties, covenants or agreements contained in this
Agreement which would give rise to the failure of a condition set forth in Section 2.3(a), which breach cannot be or has not been
cured within five days after the giving of written notice by the Company to the Purchaser specifying such breach;

 

(d)  by the
Purchaser if the Company shall have breached any of its representations, warranties, covenants or agreements contained in this
Agreement which would give rise to the failure of a condition set forth in Section 2.3(b), which breach cannot be or has not been
cured within five days after the giving of written notice by the Purchaser to the Company specifying such breach; or

 

    	 	12	 

     

    

 

(e)  by the
mutual written consent of the Company and the Purchaser

 

5.2  Entire
Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.3  Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 5:30 p.m. (New York City time)
on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30
p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

5.4  Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any
manner impair the exercise of any such right.

 

5.5  Survival.
The representations and warranties contained herein shall survive the Closing hereunder and the delivery of the Shares for a period
of twelve months.

 

5.6  Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
the interpretation of any of the provisions hereof.

 

5.7  Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Purchaser (other than in the context of a merger, sale of all or substantially all of the Common Stock or sale of all or substantially
all of the Company’s assets). The Purchaser may assign any or all of its rights under this Agreement to any Person to whom
the Purchaser assigns or transfers any Shares as permitted hereunder, provided that such transferee agrees in writing to
be bound, with respect to the transferred Shares, by the provisions of the Transaction Documents that apply to the Purchaser.

 

    	 	13	 

     

    

 

5.8  No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

5.9  Governing
Law; Jurisdiction; No Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without
regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in New York County, New York. Each party hereby irrevocably consents to the exclusive jurisdiction of the state and federal
courts sitting in New York County, New York for the adjudication of any dispute hereunder or in connection herewith or with any
transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement), and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other
manner permitted by law. If any party shall commence an action or proceeding to enforce any provisions of this Agreement, then
the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees
and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Each
party hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication of any dispute
hereunder or in connection with or arising out of this Agreement.

 

5.10  Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.11  Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

    	 	14	 

     

    

 

5.12  Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.

 

5.13  Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.14  Construction.
The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to revise the Transaction
Documents, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto.

 

5.15  Expenses.
Each party shall bear its own expenses and legal fees incurred on its behalf with respect to the negotiation, execution and consummation
of the transactions contemplated by this Agreement and the Transaction Documents.

 

(Signature Pages
Follow)

 

    	 	15	 

     

    

  

IN WITNESS WHEREOF, the parties hereto have
caused this Share Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.

 

	IBIO, INC.	 	Address for Notice:
	 	 	 	 
	By: 	/s/ Robert B. Kay	 	iBio, Inc.
	Name: 	Robert B. Kay	 	 
	Title: 	Executive Chairman and CEO	 	600 Madison Avenue, Suite 1601, New York, NY
	 	 	 	Attention: Chief Executive Officer
	 	 	 	Telephone: (302) 355-0650
	 	 	 	Facsimile: (302) 356-1173
	 	 	 	 
	 	 	 	 
	With a copy to (which shall not constitute notice):	 	Andrew Abramowitz, PLLC
	 	 	 	565 Fifth Avenue, 9th Floor
	 	 	 	New York, NY 10017
	 	 	 	Attention: Andrew Abramowitz, Esq.
	 	 	 	Telephone: (212) 972-8882
	 	 	 	Facsimile: (212) 972-8883

 

 

	EASTERN CAPITAL LIMITED	 	Address for Notice:
	 	 	 	 
	By: 	/s/ Mark VanDevelde	 	Eastern Capital Limited
	Name: 	Mark VanDevelde	 	10 Market Street No. 773
	Title: 	Director	 	Camana Bay
	 	 	 	Grand Cayman KY1-9006
	 	 	 	Attention: William Sullivan
	 	 	 	Telephone: 345-640-3330
	 	 	 	Fax: 345-945-1531

  

Address for Delivery of Shares for Purchaser (if not same as
address for notice):

 

Shares to be delivered in book entry form to:

 

Eastern Capital Limited A/C # ECL01 / 17-99237

Custodian: Northern Trust Company

DTC # 2669

Agent ID # 20290

Institution ID # 26724Exhibit 10.2

 

SHARE PURCHASE AGREEMENT

 

This Share Purchase
Agreement (this “Agreement”) is dated as of January 13, 2016 among iBio, Inc., a Delaware corporation (the “Company”),
and Eastern Capital Limited, a Cayman Islands corporation (including its successors and assigns, the “Purchaser”).

 

WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the
“Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchaser,
and the Purchaser desires to purchase from the Company, shares of common stock of the Company, as more fully described in this
Agreement.

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1             
Definitions. In addition to the terms defined elsewhere in this Agreement the following terms have the meanings set
forth in this Section 1.1:

 

“Additional
Listing Application” means an application for the listing of the Shares with the NYSE MKT in the form required by the
NYSE MKT.

 

“Additional
Shares” shall have the meaning assigned to such term in Section 4.7(b).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. With respect to the Purchaser,
any investment fund or managed account that is managed on a discretionary basis by the same investment manager as the Purchaser
will be deemed to be an Affiliate of the Purchaser. For the purposes of this Agreement, the Company and its Subsidiaries will not
be deemed an Affiliate of Purchaser or its subsidiaries and the Purchaser and its subsidiaries will not be deemed an Affiliate
of the Company or its Subsidiaries.

 

“Beneficial
Owner”, “Beneficially Own” or “Beneficial Ownership” shall have the meaning assigned
to such terms in Section 4.7(c).

 

“Board of
Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Closing”
shall have the meaning assigned to such term in Section 2.1.

 

“Closing Date”
shall have the meaning assigned to such term in Section 2.1.

 

     

     

    

 

“Commission”
means the Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, par value $0.001 per share.

 

“Company Counsel”
means Andrew Abramowitz, PLLC, with offices located at 565 Fifth Avenue, 9th Floor, New York, New York 10017.

 

“Definitive
Proxy Statement” means a Definitive Proxy Statement on Schedule 14A filed with the Commission by the Company that contains
a proposal to approve the issuance of the Shares as contemplated herein to be submitted to a vote of the stockholders of the Company
at a duly convened meeting of the stockholders of the Company.

 

“Disclosure
Schedules” shall have the meaning assigned to such term in Section 3.1.

 

“Equity Securities”
means (a) capital stock or other equity interests (including shares of Common Stock) of the Company and (b) options, warrants or
other securities that are directly or indirectly convertible into, exchangeable for or exercisable for capital stock or other equity
interests of the Company.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Financial
Statements” shall have the meaning assigned to such term in Section 3.1(f).

 

“GAAP”
shall have the meaning assigned to such term in Section 3.1(f).

 

“Indemnified
Liability” shall have the meaning assigned to such term in Section 4.5.

 

“Indemnified
Persons” shall have the meaning assigned to such term in Section 4.5.

 

“Intellectual
Property Rights” shall have the meaning assigned to such term in Section 3.1(l).

 

“Liens”
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other similar restriction.

 

“Losses”
shall have the meaning assigned to such term in Section 4.5.

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(a).

 

“Outside Date”
shall have the meaning assigned to such term in Section 5.1(a).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

    2 

     

    

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Purchase
Amount” shall have the meaning assigned to such term in Section 2.1.

 

“Purchaser
Party” shall have the meaning assigned to such term in Section 4.6.

 

“Purchaser
Statements” shall have the meaning assigned to such term in Section 3.2(h).

 

“Required
Approvals” shall have the meaning assigned to such term in Section 3.1(d).

 

“Restricted
Period” shall have the meaning assigned to such term in Section 4.7(a).

 

“SEC Documents”
shall have the meaning assigned to such term in Section 3.1(f).

 

“Shares”
shall have the meaning assigned to such term in Section 2.1.

 

“Stockholder
Approval” means approval of the issuance of the Shares as contemplated herein by a majority of votes cast at a duly convened
meeting of stockholders of the Company at which a quorum is present.

 

“Subsidiary”
means any direct or indirect subsidiary of the Company and shall, where applicable, include any direct or indirect subsidiary of
the Company formed or acquired after the date hereof.

 

“Trading Day”
means a day on which the New York Stock Exchange is open for trading.

 

“Trading Market”
means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: NYSE
MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange or the
OTC Bulletin Board.

 

“Transaction
Documents” means this Agreement and all exhibits and schedules hereto.

 

“Transfer
Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company with a mailing
address of 17 Battery Place, New York, New York 10004, and any successor transfer agent of the Company.

 

ARTICLE II

PURCHASE AND SALE

 

2.1             
Purchase and Sale; Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, the
Company agrees to sell, and the Purchaser agrees to purchase 6,500,000 shares of Common Stock (the “Shares”),
for a per Share purchase price of $0.622, resulting in an aggregate purchase price of $4,043,000 (the “Purchase Amount”).
Subject to the satisfaction of the conditions set forth in Section 2.3, the closing of the transactions contemplated hereunder
(the “Closing”) shall occur at the offices of Company Counsel on the third Trading Day following the date that
the Stockholder Approval has been obtained and the Additional Listing Application for the Shares has been approved by the NYSE
MKT or such other place or such other date as the parties may mutually agree (the “Closing Date”).

 

    3 

     

    

 

2.2             
Closing Deliveries.

 

(a)               
On the Closing Date, the Company shall deliver or cause to be delivered to the Purchaser irrevocable instructions to the
Transfer Agent instructing the Transfer Agent to deliver a certificate evidencing the Shares registered in the name of the Purchaser.

 

(b)              
On the Closing Date, the Purchaser shall deliver or cause to be delivered to the Company the Purchase Amount by wire transfer
of immediately available funds to the account notified in writing by the Company.

 

2.3             
Closing Conditions.

 

(a)               
The obligations of the Company hereunder to effect the Closing are subject to the following conditions being met:

 

(i)                
the representations and warranties of the Purchaser contained in this Agreement (A) that are not qualified as to “materiality”
shall be true and correct in all material respects as of the Closing Date, and (B) that are qualified as to “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are made as of another
date, in which case such representations and warranties shall be true and correct in all material respects or true and correct,
as the case may be, as of such specified date;

 

(ii)              
the Stockholder Approval shall have been obtained and the NYSE MKT shall have approved the Additional Listing Application
for the Shares; and

 

(iii)            
all obligations, covenants and agreements of the Purchaser required to be performed at or prior to the Closing Date shall
have been performed.

 

(b)              
The obligations of the Purchaser hereunder to effect the Closing are subject to the following conditions being met:

 

(i)                
the representations and warranties of the Company contained in this Agreement (A) that are not qualified as to “materiality”
shall be true and correct in all material respects as of the Closing Date, and (B) that are qualified as to “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are made as of another
date, in which case such representations and warranties shall be true and correct in all material respects or true and correct,
as the case may be, as of such specified date;

 

(ii)              
the Stockholder Approval shall have been obtained and the NYSE MKT shall have approved the Additional Listing Application
for the Shares;

 

(iii)            
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall
have been performed;

 

    4 

     

    

 

(iv)            
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v)              
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or
the Company’s principal Trading Market (except for any suspension of trading of limited duration agreed to by the Company,
which suspension shall be terminated prior to the Closing).

  

ARTICLE III

REPRESENTATIONS AND WARRANTIES

 

3.1             
Representations and Warranties of the Company. Except as set forth under the corresponding section of the disclosure
schedules delivered to the Purchaser concurrently herewith (the “Disclosure Schedules”), attached hereto as
Exhibit A, which Disclosure Schedules shall be deemed a part hereof, the Company hereby makes the representations and warranties
set forth below to the Purchaser as of the date hereof and as of the Closing Date (or if a date is specified in a representation
or warranty, as of such specified date):

 

(a)               
 Organization and Qualification. The Company is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the State of Delaware, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions
of its certificate of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct
business and is in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, could not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, properties or condition
(financial or otherwise) of the Company and its Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or
(iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(b)              
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by each of the Transaction Documents, to issue the Shares in accordance with the terms hereof and
otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of the Transaction Documents
by the Company and the consummation by it of the transactions contemplated hereby and thereby, including the issuance of the Shares,
have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,
the Board of Directors or the Company’s stockholders in connection therewith other than in connection with the Required Approvals.
Each Transaction Document has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company
in accordance with its terms, except as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally.

 

    5 

     

    

 

(c)               
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the other transactions contemplated hereby and thereby (including, without limitation, the issuance of the Shares)
do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or
articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any
of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations
and the rules and regulations of any Trading Market on which the Common Stock is traded or quoted), or by which any property or
asset of the Company or a Subsidiary is bound or affected, except in the cases of conflicts described in clauses (ii) or (iii)
that would not have a Material Adverse Effect.

 

(d)              
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
including but not limited to the issuance and sale of Shares, other than (i) filings required pursuant to the Exchange Act, (ii)
the Stockholder Approval, (iii) the filing of Form D with the Commission and such filings as are required to be made under applicable
state securities laws, and (iv) the filing of the Additional Listing Application (collectively, the “Required Approvals”)
and filings which if not made would not result in a Material Adverse Effect.

 

(e)               
Issuance of the Shares. The Shares are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all taxes and charges with
respect thereof and free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the
Transaction Documents. The issuance of the Shares as contemplated hereunder will not violate any preemptive or similar rights of
the holders of any shares of Common Stock or other securities of the Company.

 

    6 

     

    

 

(f)               
SEC Reports. The Company has filed all reports required to be filed by it under the Exchange Act, for
the previous two years (or such shorter period as the Company was required by law to file such material) (all of the foregoing
and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference therein,
being hereinafter referred to as the “SEC Documents”). As of their respective dates, the SEC Documents complied
in all material respects as to form with the requirements of the Securities Act and the Exchange Act and the rules and regulations
of the Commission promulgated thereunder, and none of the SEC Documents, when filed, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. The Company has advised the Purchaser that a correct and
complete copy of each of the SEC Documents (together with all exhibits and schedules thereto and as amended to date) is available
at http://www.sec.gov, a website maintained by the Commission where the Purchaser may view the SEC Documents. The financial
statements of the Company included in the SEC Documents (the “Financial Statements”) comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect
at the time of filing. Such financial statements have been prepared in all material respects in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may
be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash
flows for the periods then ended.

 

(g)              
Brokers. The Company has not employed any unaffiliated broker or finder, or incurred any liability for any brokerage
or finders fees or any similar fees or commissions in connection with the transactions contemplated by this Agreement.

 

(h)              
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. Except as disclosed in the SEC Documents, the Company has not, in the 12 months preceding the date
hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the
Company is not in compliance with the listing or maintenance requirements of such Trading Market.

 

(i)                
Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest quarterly financial
statements included within the SEC Reports, except as specifically disclosed in the SEC Reports, (A) there has been no event, occurrence
of development that has had or could reasonably be expected to result in a Material Adverse Effect, (B) the Company has not incurred
any liabilities (contingent or otherwise) other than (x) trade payables and accrued expenses incurred in the ordinary course of
business consistent with past practice and (y) liabilities not required to be reflected in the Company’s financial statements
pursuant to GAAP or required to be disclosed in filings made with the Commission, (D) the Company has not altered its method of
accounting, (E) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders
or purchased, redeemed, or made any agreements to purchase or redeem any shares of its capital stock and (F) the Company has not
issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.

 

    7 

     

    

 

(j)                
Private Placement. Assuming the accuracy of the representations and warranties of the Purchaser set forth in Section
3.2, no registration under the Securities Act is required for the offer and sale of the Shares by the Company as contemplated hereby.

 

(k)              
No Integrated Offering. With the exception of any other anticipated purchase of Common Stock from the Company by
the Purchaser, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Shares to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would
require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.

 

(l)                
Intellectual Property. Except as set forth in the SEC Reports, to the Company’s knowledge, the Company and
the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks,
trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described
in the SEC Reports as necessary or required for use in connection with their respective businesses and which the failure to so
have would have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this
Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included
within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect.
To the knowledge of the Company, all such Intellectual Property Rights are enforceable and, to the knowledge of the Company, there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have
taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

3.2             
Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as of the date
hereof and as of the Closing Date (or if a date is specified in a representation or warranty, as of such specified date) as follows:

 

(a)               
Organization; Authority. The Purchaser is an entity duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization with full right, corporate or partnership power and authority to enter into and to
consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated
by the Transaction Documents have been duly authorized by all necessary corporate or similar action on the part of the Purchaser.
Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against
it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by
laws relating to the availability of specific performance, injunctive relief or other equitable remedies, and (iii) insofar as
indemnification and contribution provisions may be limited by applicable law.

 

    8 

     

    

 

(b)              
Own Account. The Purchaser understands that the Shares are “restricted securities” and have not been
registered under the Securities Act or any applicable state securities law and is acquiring the Shares as principal for its own
account and not with a view to or for distributing or reselling such Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Shares in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to
distribute or regarding the distribution of such Shares in violation of the Securities Act or any applicable state securities law.

 

(c)               
Purchaser Status. At the time the Purchaser was offered the Shares, it was, and at the date hereof it is an “accredited
investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act. The Purchaser is not required
to be registered as a broker-dealer under Section 15 of the Exchange Act. The information set forth in the Accredited Investor
Questionnaire completed by the Purchaser and delivered to the Company is complete and accurate.

 

(d)              
Experience of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
investment in the Shares, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic
risk of an investment in the Shares and, at the present time, is able to afford a complete loss of such investment. The Purchaser
(i) has adequate means of providing for its current needs in the same manner as it would have been able to provide prior to
making the investment in the Shares, (ii) has no need for liquidity in this investment, (iii) is aware of and able to
bear the risks of this investment for an indefinite period of time and (iv) is presently able to afford a complete loss of
such investment.

 

(e)General Solicitation.
The Purchaser is not purchasing the Shares as a result of any advertisement, article, notice or other communication regarding the
Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar
or any other general solicitation or general advertisement.

 

(f)Information.
The Purchaser represents that it has access to and has reviewed copies of the Company’s SEC Documents and each of the exhibits
attached hereto. The Purchaser and its attorneys, investment advisors, business advisors, tax advisors and accountants have had
sufficient access to all documents and records pertaining to the Company and this proposed investment, including but not limited
to the SEC Documents and the exhibits attached hereto. Additionally, the Purchaser and all of its advisors have had the opportunity
to ask questions and receive answers concerning the terms and conditions of the offering and other matters pertaining to this investment,
and all such questions have been answered to the satisfaction of the Purchaser. The Purchaser and all of its advisors have had
an opportunity to obtain any additional information which the Company possesses, or can acquire without unreasonable effort or
expense, necessary to verify the accuracy of the information furnished in the SEC Documents and any exhibits attached hereto.

 

    9 

     

    

 

(g)Risk/Lack
of Market. The Purchaser recognizes that an investment in the Shares involves significant risks, including, without limitation,
those set forth in the SEC Documents. The Purchaser acknowledges that the Company’s continued operation is highly dependent
upon its ability to raise substantial additional capital and/or increase revenues. No assurance can be given that the Company will
be successful in raising any such capital and/or increasing revenues. The failure to raise such capital and/or increase revenues
will have a material adverse effect on the Company’s operations and financial condition. The Purchaser realizes that it may
not be able to sell or dispose of any of the Shares and that no market of any kind (public or private) may be available for
any of the Shares at the time the Purchaser elects to sell its Shares. In addition, the Purchaser understands that its right to
transfer the Shares will be subject to restrictions contained in applicable federal and state securities laws.

 

(h)Accuracy
of Representations of Purchaser. The representations, warranties and agreements made by the Purchaser herein have been made
with the intent that they be relied upon by the Company for purposes of the transactions contemplated by this Agreement. The Purchaser
represents and warrants that none of the representations or warranties made by the Purchaser herein or the Accredited Investor
Questionnaire submitted by the Purchaser to the Company (“Purchaser Statements”) contains any false or misleading
statement or omits to state a material fact.

 

ARTICLE IV

OTHER AGREEMENTS OF THE PARTIES

 

4.1             
Transfer Restrictions.

 

(a)               
The Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of Shares other than pursuant to an effective registration statement or an exemption under the Securities Act, the Company may
require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such
transfer does not require registration of such transferred Shares under the Securities Act. As a condition of any transfer, any
such transferee, other than with respect to a transfer pursuant to a registration statement or an exemption under the Securities
Act, shall agree in writing to be bound by the terms of this Agreement and shall have the rights of the Purchaser under this Agreement.

 

(b)              
The Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares substantially
in the following form:

 

    10 

     

    

 

THESE SHARES HAVE NOT
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL
BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

4.2             
Use of Proceeds. The Company shall use the net proceeds from the sale of the Shares hereunder for general corporate
purposes.

 

4.3             
Stockholders’ Meeting. The Company agrees to use its commercially reasonable efforts to call and hold as promptly
as reasonably practicable following the date hereof, but in no event later than March 31, 2016, a meeting of the stockholders of
the Company to vote on a proposal to approve the issuance of the Shares as contemplated herein, and as promptly as reasonably practicable
following the date hereof, the Company will prepare and file with the Commission a proxy statement to be sent to the Company’s
stockholders in connection with such proposal and stockholders’ meeting. Promptly following the date that the Stockholder
Approval is obtained, the Company shall submit the Additional Listing Application to the NYSE MKT, if such Additional Listing Application
has not been submitted prior to such date.

 

4.4             
Form D. The Company agrees to timely file a Form D with respect to the Shares as required under Regulation D and
to provide a copy thereof, promptly upon request of the Purchaser.

 

4.5             
Indemnification by Purchaser. The Purchaser shall indemnify the Company and its stockholders, directors, officers,
employees, agents and any of the affiliates of the foregoing (the “Indemnified Persons”) and hold harmless the
Indemnified Persons from and against any and all loss, cost, liability, damages, penalties, actions, suits, and expenses (including
reasonable attorneys’ fees and other legal expenses) (“Losses”) which may be imposed upon, asserted against,
paid or incurred by the Indemnified Persons (except and only to the extent that the same arises solely from gross negligence or
willful misconduct on the part of an Indemnified Person) at any time or from time to time in connection with the enforcement of
the terms hereof or of any Transaction Document against the Purchaser, or related to the consummation of the transactions contemplated
hereby or under any Transaction Document with respect to the Purchaser, including the prosecution or defense of any suit against
the Purchaser relating to or arising out of this Agreement or any Transaction Document, or any breach by the Purchaser of its representations
and warranties hereunder or under any Transaction Document or the default by the Purchaser under this Agreement or any Transaction
Document (collectively the “Indemnified Liability”); provided, however, that the Purchaser shall
not be liable for the payment to any Indemnified Person of any portion of such Indemnified Liability resulting from the gross negligence
or willful misconduct on the part of an Indemnified Person. If any action shall be brought against any Indemnified Person in respect
of which indemnity may be sought pursuant to this Agreement, such Indemnified Person shall promptly notify the Purchaser in writing,
and the Purchaser shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to
the Indemnified Person. Any Indemnified Person shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person except to
the extent that (i) the employment thereof has been specifically authorized by the Purchaser in writing, (ii) the Purchaser has
failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the
reasonable opinion of such separate counsel, a material conflict on any material issue between the position of the Purchaser and
the position of such Indemnified Person, in which case the Purchaser shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Purchaser will not be liable to any Indemnified Person under this Agreement (i)
for any settlement by a Indemnified Person effected without the Purchaser’s prior written consent, which shall not be unreasonably
withheld or delayed or (ii) to the extent, but only to the extent, that a loss, claim, damage or liability is attributable to any
Indemnified Person’s breach of any of the representations, warranties, covenants or agreements made by such Indemnified Person
in this Agreement or any Transaction Document.

 

    11 

     

    

 

4.6             
Indemnification by Company. The Company shall indemnify the Purchaser and its directors, officers, shareholders,
members, partners, employees and agents (each, a “Purchaser Party”) and hold harmless the Purchaser Parties
from and against any and all Losses which may be imposed upon, asserted against, paid or incurred by the Purchaser Parties (except
and only to the extent that the same arises solely from gross negligence or willful misconduct on the part of a Purchaser Party)
at any time or from time to time in connection with (a) any breach of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or any Transaction Document or (b) any action instituted against the Purchaser, or any of
its Affiliates, by any stockholder of the Company who is not an Affiliate of the Purchaser, with respect to any of the transactions
contemplated by this Agreement (unless such action is based upon a breach of the Purchaser’s representations, warranties
or covenants under this Agreement or any agreements or understandings the Purchaser may have with any such stockholder or any violations
by the Purchaser of state or federal securities laws or any conduct by the Purchaser which constitutes fraud, gross negligence,
willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment
thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel,
a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which
case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company
will not be liable to any Purchaser Party under this Agreement (i) for any settlement by a Purchaser Party effected without the
Company’s prior written consent, which shall not be unreasonably withheld or delayed or (ii) to the extent, but only to the
extent, that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or any Transaction Document.

 

    12 

     

    

 

4.7             
Standstill Agreement.

 

(a)               
During the period beginning on the Closing Date and ending on the third anniversary of the Closing Date (the “Restricted
Period”), the Purchaser covenants and agrees that, unless invited in writing with the approval of a majority of the whole
Board of Directors, it will not, and will not cause or permit any of its controlled Affiliates to, directly or indirectly:

 

(i)                
acquire, offer to acquire or agree to acquire, by purchase or otherwise, Beneficial Ownership of any Equity Securities (other
than Additional Shares acquired in accordance with paragraph (b) hereof or any Shares or Additional Shares pursuant to any stock
dividend, stock split or other recapitalization or reclassification of the Common Stock or pursuant to any shareholder rights or
similar plan) or any other security, including any cash-settled option or other derivative security, that transfers all or any
portion of the economic benefits or risks of the ownership of Equity Securities to the Purchaser or any of its controlled Affiliates;

 

(ii)              
make any statement or proposal to the Company or any of the Company’s stockholders regarding, or make any public announcement,
proposal or offer (including any “solicitation” of “proxies” as such terms are defined or used in Regulation
14A of the Exchange Act) with respect to, or otherwise solicit or effect, or seek or offer or propose to effect (whether directly
or indirectly, publicly or otherwise) (A) any business combination, merger, tender offer, exchange offer or similar transaction
involving the Company or any of its Subsidiaries, (B) any restructuring, recapitalization, liquidation, dissolution or similar
transaction involving the Company or any of its Subsidiaries, including any divestiture, break-up or spinoff, or (C) any acquisition
of any of the Company’s or its Subsidiary’s equity securities or rights or options to acquire interests in the Company’s
or its Subsidiary’s equity securities;

 

(iii)            
negotiate, have any discussions or act in concert with, or advise or knowingly finance, assist or encourage, any other Person
in connection with any of the actions set forth in clauses (i) and (ii) above (it being understood that, without limiting the generality
of the foregoing, the Purchaser and its controlled Affiliates will not be permitted to act as a joint bidder or co-bidder with
any other Person with respect to any of the actions set forth in clause (ii) above);

 

(iv)            
request, call or seek to call a meeting of the stockholders of the Company, nominate any individual for election as a director
of the Company at any meeting of stockholders of the Company, submit any stockholder proposal (pursuant to Rule 14a-8 promulgated
under the Exchange Act or otherwise) to seek representation on the Board of Directors or any other proposal to be considered by
the stockholders of the Company, or publicly recommend that any other stockholder vote in favor of, or otherwise publicly comment
favorably about, or solicit votes or proxies for, any such nomination or proposal submitted by another stockholder of the Company,
or otherwise publicly seek to control or influence the Board of Directors, management or policies of the Company;

 

    13 

     

    

 

(v)              
deposit any shares of the voting stock of the Company in a voting trust or similar arrangement or subject any shares of
voting stock of the Company to any voting agreement, pooling arrangement or similar arrangement;

 

(vi)            
take any action which would reasonably be expected to require the Company or any of its Affiliates to make a public announcement
regarding any of the actions set forth in this paragraph (a); or

 

(vii)          
request that the Company, directly or indirectly, amend, waive or terminate any provision of this paragraph (a) (including
this sentence), unless and until the Person seeking such amendment, waiver or termination has received the prior written invitation
or approval of the Company.

 

(b)              
Notwithstanding paragraph (a) hereof, the Purchaser will be entitled to purchase, from time to time in one or more transactions,
in the open market or in privately negotiated transactions with holders of outstanding shares of Common Stock, additional shares
of Common Stock (any such shares so acquired, the “Additional Shares”); provided that, when taken together
with all other shares of Common Stock Beneficially Owned by the Purchaser and its controlled Affiliates at the time such transaction
is consummated, such purchase will not as of the time of such purchase result in the Purchaser and its controlled Affiliates being
the Beneficial Owner of more than 38% of the aggregate number of shares of Common Stock outstanding, as reported in the most recent
report filed by the Company with the Securities and Exchange Commission containing such information as of such time.

 

(c)               
For the purposes of this Section 4.7, a Person will be deemed the “Beneficial Owner” of, to “Beneficially
Own” or have “Beneficial Ownership” of any securities (and correlative terms will have correlative
meanings): (i) which such Person or any of such Person’s Affiliates beneficially own, directly or indirectly, for purposes
of Section 13(d) of the Exchange Act and Regulations 13D and 13G thereunder; (ii) which such Person or any of such Person’s
Affiliates has (A) the right to acquire (whether such right is exercisable immediately or only after the passage of time or the
fulfillment of a condition or both) pursuant to any agreement, arrangement or understanding (whether or not in writing), or upon
the exercise of conversion rights, exchange rights, warrants, options or otherwise or ( B) the right to vote, alone or in concert
with others, pursuant to any agreement, arrangement or understanding (whether or not in writing); (iii) which are beneficially
owned, directly or indirectly, by any other Person with which such Person or any of such Person’s Affiliates has any agreement,
arrangement or understanding (whether or not in writing) for the purpose of acquiring, holding, voting or disposing of any securities
of the Company; or (iv) which are the subject of, or the reference securities for or that underlie any derivative transaction entered
into by such Person, or derivative security (including options) acquired by such Person, which gives such Person the economic equivalent
of ownership of an amount of such securities due to the fact that the value of the derivative is directly or indirectly determined
by reference to the price or value of such securities, without regard to whether (A) such derivative conveys any voting rights
in such securities to such Person, (B) the derivative is required to be, or capable of being, settled through delivery of such
securities or (C) such Person may have entered into other transactions that hedge the economic effect of such derivative.

 

    14 

     

    

 

In determining the number of shares deemed
Beneficially Owned by virtue of the operation of clause (iv) above, the subject Person will be deemed to Beneficially Own (without
duplication) the number of shares that are synthetically owned pursuant to such derivative transactions or such derivative securities.
The number of shares that are synthetically owned will be the notional or other number of shares in respect of such derivative
transactions or securities that is specified in a filing by such Person or any of such Person’s Affiliates with the Commission
or in the documentation evidencing such derivative transactions or securities, and in any case (or if no such number of shares
is specified in any filing or documentation), as reasonably determined by the Board of Directors in good faith to be the number
of shares that are synthetically owned pursuant to such derivative transactions or securities

 

ARTICLE V

 

MISCELLANEOUS

 

5.1             
Termination. This Agreement may be terminated at any time prior to the Closing:

 

(a)               
by either the Company or the Purchaser, if the Closing shall not have occurred by March 31, 2016 (the “Outside
Date”); provided, however, that the right to terminate this Agreement under this Section 5.1(a) shall not
be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have
resulted in, the failure of the Closing to occur on or prior to such date;

 

(b)              
by the Company or the Purchaser if, at a duly convened meeting of stockholders of the Company (or any adjournment thereof)
at which a proposal to approve the issuance of the Shares as contemplated herein has been voted upon, the Company stockholders
fail to approve such proposal;

 

(c)               
by either the Company or the Purchaser if there shall be in effect any final and nonappealable law, order or other legal
restraint or prohibition by any governmental, regulatory, listing or administrative authority, agency or commission or any court,
tribunal or judicial body preventing or making illegal the consummation of the transactions contemplated hereby;

 

(d)              
by the Company if the Purchaser shall have breached any of its representations, warranties, covenants or agreements contained
in this Agreement which would give rise to the failure of a condition set forth in Section 2.3(a), which breach cannot be or has
not been cured within five days after the giving of written notice by the Company to the Purchaser specifying such breach;

 

(e)               
by the Purchaser if the Company shall have breached any of its representations, warranties, covenants or agreements contained
in this Agreement which would give rise to the failure of a condition set forth in Section 2.3(b), which breach cannot be or has
not been cured within five days after the giving of written notice by the Purchaser to the Company specifying such breach; or

 

(f)               
by the mutual written consent of the Company and the Purchaser.

 

    15 

     

    

 

5.2             
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral
or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.3             
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the
date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom
such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto.

 

5.4             
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a
written instrument signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right.

 

5.5             
Survival. The representations and warranties contained herein shall survive the Closing hereunder and the delivery
of the Shares for a period of twelve months.

 

5.6             
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not
be deemed to limit or affect the interpretation of any of the provisions hereof.

 

5.7             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Purchaser (other than in the context of a merger, sale of all or substantially all of the Common Stock or sale of
all or substantially all of the Company’s assets). The Purchaser may assign any or all of its rights under this Agreement
to any Person to whom the Purchaser assigns or transfers any Shares as permitted hereunder, provided that such transferee
agrees in writing to be bound, with respect to the transferred Shares, by the provisions of the Transaction Documents that apply
to the Purchaser.

 

5.8             
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

    16 

     

    

 

5.9             
Governing Law; Jurisdiction; No Jury Trial. All questions concerning the construction, validity, enforcement and
interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State
of Delaware, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in
the state and federal courts sitting in New York County, New York. Each party hereby irrevocably consents to the exclusive jurisdiction
of the state and federal courts sitting in New York County, New York for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement),
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for
such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law. If any party shall commence an action or proceeding to enforce any provisions
of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
or proceeding. Each party hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication
of any dispute hereunder or in connection with or arising out of this Agreement.

 

5.10         
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such facsimile or “.pdf” signature page were an original thereof.

 

5.11         
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

    17 

     

    

 

5.12         
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, each of the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any
such obligation the defense that a remedy at law would be adequate.

 

5.13         
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of
any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised
on the next succeeding Business Day.

 

5.14         
Construction. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity
to revise the Transaction Documents, and, therefore, the normal rule of construction to the effect that any ambiguities are to
be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto.

 

5.15         
Expenses. Each party shall bear its own expenses and legal fees incurred on its behalf with respect to the negotiation,
execution and consummation of the transactions contemplated by this Agreement and the Transaction Documents.

 

(Signature Pages
Follow)

 

    18 

     

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Share Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.

 

	IBIO, INC.	 	Address for Notice:
	 	 	 	 
	By: 	/s/ Robert B. Kay	 	iBio, Inc.
	Name: 	Robert B. Kay	 	 
	Title: 	Executive Chairman and CEO	 	600 Madison Avenue, Suite 1601, New York, NY
	 	 	 	Attention: Chief Executive Officer
	 	 	 	Telephone: (302) 355-0650
	 	 	 	Facsimile: (302) 356-1173
	 	 	 	 
	 	 	 	 
	With a copy to (which shall not constitute notice):	 	Andrew Abramowitz, PLLC
	 	 	 	565 Fifth Avenue, 9th Floor
	 	 	 	New York, NY 10017
	 	 	 	Attention: Andrew Abramowitz, Esq.
	 	 	 	Telephone: (212) 972-8882
	 	 	 	Facsimile: (212) 972-8883

 

 

	EASTERN CAPITAL LIMITED	 	Address for Notice:
	 	 	 	 
	By: 	/s/ Mark VanDevelde	 	Eastern Capital Limited
	Name: 	Mark VanDevelde	 	10 Market Street No. 773
	Title: 	Director	 	Camana Bay
	 	 	 	Grand Cayman KY1-9006
	 	 	 	Attention: William Sullivan
	 	 	 	Telephone: 345-640-3330
	 	 	 	Fax: 345-945-1531

 

Address for Delivery of Shares for Purchaser (if not same as
address for notice):

 

Shares to be delivered in book entry form to:

 

Eastern Capital Limited A/C # ECL01 / 17-99237

Custodian: Northern Trust Company

DTC # 2669

Agent ID # 20290

Institution ID # 26724

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]